Vext Reports Q2 2026 Financial Results; Opens Sixth Ohio Dispensary, Completes Arizona Cultivation Wind-Down; Adjusted EBITDA Grows for Second Consecutive Quarter

Revenue was $12.1M, flat vs. Q1 2026, as Ohio growth offset the planned Arizona cultivation wind-down. Adjusted EBITDA rose 22% to $3.4M, while the net loss narrowed 79% year-over-year to $(0.3)M, signaling improving profitability despite steady top-line performance.

Analysis

Revenue was $12.1M, flat vs. Q1 2026, as Ohio growth offset the planned Arizona cultivation wind-down. Adjusted EBITDA rose 22% to $3.4M, while the net loss narrowed 79% year-over-year to $(0.3)M, signaling improving profitability despite steady top-line performance.